Healthcare

Cartilage Degeneration Market Forecast 2024-2033: Growth Rate, Drivers, And Trends|johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc.

The Cartilage Degeneration Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Cartilage Degeneration Market:
https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report

According to The Business Research Company’s Cartilage Degeneration Global Market Report 2024, The cartilage degeneration market size has grown strongly in recent years. It will grow from $11.88 billion in 2023 to $12.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to aging population, joint injuries, obesity epidemic, sports injuries, limited self-repair capacity.

The cartilage degeneration market size is expected to see strong growth in the next few years. It will grow to $15.64 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to regenerative medicine advancements, biologic injections, tissue engineering solutions, precision medicine, robotics-assisted surgery. Major trends in the forecast period include stem cell therapies, 3d printing in orthopedics, gene therapy for cartilage repair, personalized rehabilitation programs, telemedicine for follow-up care.

The increasing prevalence of obesity is expected to propel the growth of the cartilage degeneration market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat to the extent that it may harm a person’s health. Obesity can initiate and accelerate cartilage degeneration by increasing cartilage compressive forces and inflammatory cytokines. Obesity induces several pathological changes to the whole knee joint structure, including abnormal loading on the joint, joint malalignment, and muscle weakness. For instance, in May 2023, according to the Government Digital Service, a UK-based government body, in 2021–2022, around 63.8% of adults aged 18 years and over were overweight or living with obesity, an increase from 63.3% from the previous year. Further, among adults, 25.9% were estimated to be obese, which increased by 25.2% from 2020 to 2021. Therefore, the increasing prevalence of obesity is driving the growth of the cartilage degeneration market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13103&type=smp

The cartilage degeneration market covered in this report is segmented –

1) By Procedure: Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell-Based Cartilage Resurfacing, Autologous Chondrocyte Implantation, Other Procedures
2) By Application: Knee, Hip, Other Applications
3) By End User: Hospitals And Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes

Major companies operating in the cartilage degeneration market are developing innovative products, such as Agili-C, to support bone remodeling and cartilage regeneration. Agili-C is a cell-free, off-the-shelf implant used to repair cartilage and osteochondral defects in traumatic and osteoarthritic joints. For instance, in July 2023, CartiHeal Ltd., an Israel-based medical device company, announced its first commercial implantation of Agili-C. The implant’s goal is to encourage the natural process of articular cartilage and subchondral bone regeneration rather than relying on cells or growth factors. The implant is made from natural calcium carbonate, aragonite, derived from coral exoskeletons. The implant stimulates chondrocytes from the surrounding cartilage to migrate into the scaffold, depositing an extracellular matrix. This approval adds value to the implant by reassuring patients and healthcare providers that it is a safe and effective treatment option.

The cartilage degeneration market report table of contents includes: